Real-world observational cohort study of treatment patterns and safety outcomes of infliximab biosimilar CT-P13 for the treatment of inflammatory bowel disease (CONNECT-IBD).
Bernd BokemeyerTibor HlavatyMatthieu AllezPamela SelemaShahrzad MoosaviMary Jane CadatalHeather FowlerMarkus MuellerKatherine F LiauFrancisco Javier García-AlonsoPublished in: Expert opinion on biological therapy (2023)
: ClinicalTrials.gov NCT02539368.